Stereotaxis News

SmarTrend, our proprietary pattern recognition system, called a Downtrend for Stereotaxis on November 02, 2009 at $3.69. Since then, Stereotaxis has returned 3% as of today's recent price of $3.58. Want to profit from these alerts? Go to www.mysmartrend.com now for a FREE two-week trial.

The report also includes earnings and earnings per share, margin and return ratios, financial strength, growth ratios, dayA's sales outstanding, dayA's outstanding inventory, cash and short-term investments per share and total common shares outstanding.

The National Institutes of Health has awarded researchers at Rice University and the Texas Heart Institute a $1 million Challenge Grant to refine cell-tracking nanotube technology that could make magnetic resonance imaging up to 40 times more sensitive than existing MRIs and help guide adult stem cells within the human body to repair damaged ...

BUYINS.NET / www.squeezetrigger.com is monitoring the performance of all stocks with earnings being released Thursday, November 5th and determining how the stocks have performed after their last 12 quarterly, 6 quarterly and November earnings reports.

The product is the fifth advanced ablation catheter resulting from the on-going co-development agreement between Stereotaxis and Biosense Webster to design and distribute magnetically enabled catheters for use in the Niobe Magnetic Navigation System .

Chief Executive Mike Kaminski said the public offering and credit-line extension will allow the company to epand its cardiac applications.

Several companies are tapping the equity markets today. Medical device maker Stereotaxis, whose products treat coronary artery disease and arrhythmias, announced Friday it is selling 6.5 million shares for $4 each.

Stereotaxis , a medical device firm that emerged four years ago from St. Louis' Center for Emerging Technologies incubator, attracted $18.8 million in new capital last December despite the economic downturn.

Stock futures were down on interest rate concerns after comments by Federal Reserve Chairman Ben Bernake.

Companies mentioned in this article: Stereotaxis, Inc. ST. LOUIS, Oct. 8 /PRNewswire-FirstCall/ -- Stereotaxis, Inc.

Stereotaxis, Inc. today announced that it has received a commitment letter from Silicon Valley Bank, a member company of SVB Financial Group , to increase and extend its credit facility.

Stereotaxis, Inc. , announced that the Texas Cardiac Arrhythmia Institute at St.

Stereotaxis Inc. said Novation , a health-care supply contracting company, will add Stereotaxis' equipment for treating heart problems to its capital products contract portfolio.

Integrity Media announces the availability of the report "Drilling in the Fields of Opportunity" related to the medical device industry featuring SenoRx, Inc.

For months, doctors were baffled by Nicole Milzarski's tachycardia, a rapid heartbeat emanating from a hard-to-access part of her heart.

Stereotaxis Inc. lost $7.4 million during the three months ended June 30. That compares with a loss of $12.8 million during the same period a year ago.